Abstract
Topical minoxidil (MXD) is frequently used as therapy for alopecia. In this study, a new MXD molecular salt formed by MXD and the 2,4-dihydroxybenzoic acid (24HA) were prepared and characterized. The nature of the MXD/24HA salt was studied using infrared spectrometry, single-crystal and powder X-ray diffraction, X-ray photoelectron spectroscopy, Hirshfeld surface analysis, and configuration interaction calculations. The theoretical results and the experimental data show that the proton transfer accompanies the formation of the MXD/24HA salt. The resulted MXD/24HA salt crystallizes in themonoclinic space group P21/c. The in vivo assessment with the hair growth model in mice reveals that the MXD/24HA salt is superior to the raw MXD. Thus, the MXD/24HA salt can potentially be a candidate drug for hair loss. The combination of theory and experiment enables an innovative methodology to understand the differences in structure and properties of pharmaceutical salts.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.